GSA CAPITAL PARTNERS LLP - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 164 filers reported holding WUXI PHARMATECH CAYMAN INC in Q4 2013. The put-call ratio across all filers is 0.55 and the average weighting 0.6%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q2 2015$2,123,000
+51.4%
50,240
+38.9%
0.08%
+46.4%
Q1 2015$1,402,000
+58.6%
36,158
+37.7%
0.06%
-9.7%
Q4 2014$884,000
-36.4%
26,266
-33.8%
0.06%
-15.1%
Q3 2014$1,389,000
+39.6%
39,666
+31.1%
0.07%
+62.2%
Q2 2014$995,000
+28.1%
30,266
+43.5%
0.04%
-18.2%
Q1 2014$777,000
-23.0%
21,088
-19.8%
0.06%
-31.2%
Q4 2013$1,009,000
-4.9%
26,288
-32.1%
0.08%
-4.8%
Q3 2013$1,061,000
+44.7%
38,734
+11.0%
0.08%
-3.4%
Q2 2013$733,00034,9050.09%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q4 2013
NameSharesValueWeighting ↓
Coupland Cardiff Asset Management LLP 448,361$15,096,00021.12%
Sloane Robinson LLP 107,400$3,616,0006.28%
Sensato Investors LLC 327,754$11,035,0003.26%
Grandeur Peak Global Advisors, LLC 388,810$13,091,0002.94%
GRATRY & Co LLC 205,800$7,899,0002.59%
THOMAS WHITE INTERNATIONAL LTD 464,926$15,654,0002.15%
COMGEST GLOBAL INVESTORS S.A.S. 1,819,980$61,279,0001.87%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 1,169,686$39,383,0001.64%
Ninety One North America, Inc. 133,372$4,491,0001.32%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 87,560$2,948,0001.27%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders